傳上周中概股急瀉涉南韓基金遭斬倉
《CNBC》引述消息報道,上周五(26日)部分美國媒體股及中國互聯網美國預託證券遭大規模沽售,涉及南韓Archegos資本遭斬倉。Archegos資本由老虎基金管理前證券分析師Bill Hwang創辦。消息指因高槓桿引發「追孖展」,最終導致斬倉。
報道指受影響股份包括ViacomCBS(VIAC.US)、Discovery(DISCA.US)、百度(09888.HK)(BIDU.US)、騰訊音樂(TME.US)及唯品會(VIPS.US)等。其中ViacomCBS及Discovery各跌逾27%,兩者單周跌幅分別為逾50%及45%,兩股均有大量淡倉。另外,百度及唯品會單周跌幅分別超過18%及31%,騰訊音樂跌逾33%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.